戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cranial hypertension such as cerebral venous sinus thrombosis.
2        Eighteen patients had suspected dural sinus thrombosis.
3                 Diagnosis of cerebral venous sinus thrombosis.
4 ternational Study on Cerebral Vein and Dural Sinus Thrombosis.
5         Thirty patients (88%) had transverse sinus thrombosis.
6 s and were confirmed to have cerebral venous sinus thrombosis, 12 (30%) had clinical deterioration an
7 intracranial hemorrhage due to delayed dural sinus thrombosis after endovascular treatment of his cho
8 usion and left transverse and sigmoid venous sinus thrombosis, along with left jugular vein thrombosi
9 cephalopathy associated with cerebral venous sinus thrombosis and disseminated primary JCPyV infectio
10  rapid, useful method for diagnosis of dural sinus thrombosis and for preoperative mapping of venous
11  also be considered, such as cerebral venous sinus thrombosis and reversible cerebral vasoconstrictio
12                Clinical settings were venous sinus thrombosis and seizure (n = 3), hemiplegic migrain
13 tis, ischemic and hemorrhagic stroke, venous sinus thrombosis, and endothelialitis.
14 ciated deep vein thrombosis, cerebral venous sinus thrombosis, and for patients with atrial fibrillat
15 al retinal artery occlusion, cerebral venous sinus thrombosis, and left ventricular thrombus.
16 nd age-adjusted incidence of cerebral venous sinus thrombosis before the COVID-19 pandemic with that
17 tive patients diagnosed with cerebral venous sinus thrombosis between January 1987 and March 2018 fro
18  to 5.2) among patients with cerebral venous sinus thrombosis, by a factor of 1.7 (95% CI, 1.3 to 2.3
19 tured intracranial aneurysm, cerebral venous sinus thrombosis, cervical artery dissection, acute hype
20 ipating in the International Cerebral Venous Sinus Thrombosis Consortium from Finland, the Netherland
21 nd sometimes fatal, cases of cerebral venous sinus thrombosis (CVST) and thrombocytopenia following t
22                              Cerebral venous sinus thrombosis (CVST) is a rare but life-threatening e
23                              Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare an
24 ets of the primary outcomes: cerebral venous sinus thrombosis (CVST), ischaemic stroke, myocardial in
25                              Cerebral venous sinus thrombosis (CVST), though a recognized complicatio
26  thrombocytopenia (VITT), is cerebral venous sinus thrombosis (CVST).
27  a possible association with cerebral venous sinus thrombosis (CVST).
28 ed alanine aminotransferase, cerebral venous sinus thrombosis, grade 3 increased amylase, and grade 4
29 dial infarction, Bell palsy, cerebral venous sinus thrombosis, Guillain-Barre syndrome, myocarditis/p
30 few reported cases of SAH secondary to dural sinus thrombosis; however most of these are convexity he
31 4.46, p=0.01) and isolated superior sagittal sinus thrombosis (HR=0.39, 95% CI=0.14 to 1.04, p=0.05)
32 with the most frequent being cerebral venous sinus thrombosis in combination with pulmonary embolism
33                     Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia ha
34 esia in one patient and suggested transverse sinus thrombosis in two patients in whom 3D MR venograph
35 e sample of 93 patients with cerebral venous sinus thrombosis included in the laboratory analysis, 8
36 chnoid hemorrhage and extensive dural venous sinus thrombosis involving the superior sagittal sinus a
37 luded pulmonary embolism and cerebral venous sinus thrombosis (n = 1 for each).
38  of stroke (arterial, n = 3; cerebral venous sinus thrombosis, n = 4), thrombocytopenia (median plate
39  (0%; 95% CI, 0%-0.01%), and cerebral venous sinus thrombosis (no individuals) consistent with result
40  and effective treatment for cerebral venous sinus thrombosis not responding to anticoagulation.
41 nteral nutrition (one patient), and sagittal sinus thrombosis (one patient).
42                                              Sinus thrombosis presenting as diffuse SAH is extremely
43             In patients with cerebral venous sinus thrombosis prior to the COVID-19 pandemic, baselin
44 ical manifestations included cerebral venous sinus thrombosis, splanchnic vein thrombosis, arterial c
45 of coinciding cerebral infarction and venous sinus thrombosis unveiling the diagnosis of celiac disea
46 tal vein thrombosis, transverse and sagittal sinus thrombosis, upper- and lower-extremity thrombosis,
47                              No dural venous sinus thrombosis was detected for any astronaut.
48                                        Dural sinus thrombosis was diagnosed in seven patients, with m
49                                        Dural sinus thrombosis was found in four patients.
50 nt on imaging, but transient cerebral venous sinus thrombosis was present.
51                     Rates of cerebral venous sinus thrombosis were higher than otherwise expected aft
52 Germany, and the UK reported cerebral venous sinus thrombosis with thrombocytopenia and anti-platelet
53 COV2.S COVID-19 vaccines and cerebral venous sinus thrombosis with thrombocytopenia.